Methods of treating C1s-mediated diseases and conditions and compositions thereof
US6492403B1 · kind B1 · utility
9Cited by
2References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 9, 2000 |
| Grant date | Dec 10, 2002 |
| Priority date | — |
| Expiry date | Feb 9, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a method for treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade, comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of Formula I or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R1, R2, R3, R4, X, Y and Z are defined in the specification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.